Achilles Therapeutics
(NASDAQ:ACHL)
$2.30
-0.15[-6.12%]
Last update: 2:24PM
Day Range2.25 - 2.5252 Wk Range1.84 - 5.35Open / Close2.42 / -Float / Outstanding39.2M / 40.8M
Vol / Avg.11.1K / 38.1KMkt Cap93.8MP/E-50d Avg. Price2.9
Div / Yield-Payout Ratio-Total Float39.2MEPS-0.44

Achilles Therapeutics Stock (NASDAQ:ACHL), Quotes and News Summary

Achilles Therapeutics Stock (NASDAQ: ACHL)

Day Range2.25 - 2.5252 Wk Range1.84 - 5.35Open / Close2.42 / -Float / Outstanding39.2M / 40.8M
Vol / Avg.11.1K / 38.1KMkt Cap93.8MP/E-50d Avg. Price2.9
Div / Yield-Payout Ratio-Total Float39.2MEPS-0.44
Sector: Health Care.Industry: Biotechnology
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-08
REV
Q2 2022Est.ActualSurprise
EPS-0.560-0.440 0.1200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Achilles Therapeutics Questions & Answers

Q
How do I buy Achilles Therapeutics (ACHL) stock?
A

You can purchase shares of Achilles Therapeutics (NASDAQ: ACHL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Achilles Therapeutics's (ACHL) competitors?
Q
What is the target price for Achilles Therapeutics (ACHL) stock?
A

The latest price target for Achilles Therapeutics (NASDAQ: ACHL) was reported by JP Morgan on Monday, April 26, 2021. The analyst firm set a price target for 11.00 expecting ACHL to rise to within 12 months (a possible 378.26% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Achilles Therapeutics (ACHL)?
A

The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $2.3 last updated Today at September 30, 2022, 6:24 PM UTC.

Q
Does Achilles Therapeutics (ACHL) pay a dividend?
A

There are no upcoming dividends for Achilles Therapeutics.

Q
When is Achilles Therapeutics (NASDAQ:ACHL) reporting earnings?
A

Achilles Therapeutics’s Q3 earnings are confirmed for Tuesday, November 8, 2022.

Q
Is Achilles Therapeutics (ACHL) going to split?
A

There is no upcoming split for Achilles Therapeutics.

Q
What sector and industry does Achilles Therapeutics (ACHL) operate in?
A

Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.